Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond J Deshaies

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
Nature|April 11, 2009
Drug discovery: Fresh target for cancer therapyRaymond J Deshaies
Nature Chemical Biology|October 21, 2015
Corrigendum: Protein degradation: Prime time for PROTACsRaymond J Deshaies
Nature Reviews. Drug Discovery|August 1, 2025
How multispecific molecules are transforming pharmacotherapyRaymond J Deshaies
Nature|July 22, 2014
Structural biology: Corralling a protein-degradation regulatorRaymond J Deshaies
Nature|April 17, 2020
Multispecific drugs herald a new era of biopharmaceutical innovationRaymond J Deshaies
Nature Chemical Biology|August 19, 2015
Protein degradation: Prime time for PROTACsRaymond J Deshaies
BMC Biology|November 12, 2014
Proteotoxic crisis, the ubiquitin-proteasome system, and cancer therapyRaymond J Deshaies
Molecular Biology of the Cell|March 16, 2007
A conditional yeast E1 mutant blocks the ubiquitin-proteasome pathway and reveals a role for ubiquitin conjugates in targeting Rad23 to the proteasomeNazli Ghaboosi, Raymond J Deshaies
Molecular Cell|October 15, 2008
Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugationAnjanabha Saha, Raymond J Deshaies
BMC Genetics|March 27, 2002
Multiple telophase arrest bypassed (tab) mutants alleviate the essential requirement for Cdc15 in exit from mitosis in S. cerevisiaeWenying Shou, Raymond J Deshaies
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Nature|April 11, 2009
Drug discovery: Fresh target for cancer therapyRaymond J Deshaies
Nature Chemical Biology|October 21, 2015
Corrigendum: Protein degradation: Prime time for PROTACsRaymond J Deshaies
Nature Reviews. Drug Discovery|August 1, 2025
How multispecific molecules are transforming pharmacotherapyRaymond J Deshaies
Nature|July 22, 2014
Structural biology: Corralling a protein-degradation regulatorRaymond J Deshaies
Nature|April 17, 2020
Multispecific drugs herald a new era of biopharmaceutical innovationRaymond J Deshaies
Nature Chemical Biology|August 19, 2015
Protein degradation: Prime time for PROTACsRaymond J Deshaies
BMC Biology|November 12, 2014
Proteotoxic crisis, the ubiquitin-proteasome system, and cancer therapyRaymond J Deshaies
Molecular Biology of the Cell|March 16, 2007
A conditional yeast E1 mutant blocks the ubiquitin-proteasome pathway and reveals a role for ubiquitin conjugates in targeting Rad23 to the proteasomeNazli Ghaboosi, Raymond J Deshaies
Molecular Cell|October 15, 2008
Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugationAnjanabha Saha, Raymond J Deshaies
BMC Genetics|March 27, 2002
Multiple telophase arrest bypassed (tab) mutants alleviate the essential requirement for Cdc15 in exit from mitosis in S. cerevisiaeWenying Shou, Raymond J Deshaies
Pageof 12